Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and neurokinin a (4-10), beta-ala(8)-

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with neurokinin a (4-10), beta-ala(8)- in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)
Studies
(neurokinin a (4-10), beta-ala(8)-)
Trials
(neurokinin a (4-10), beta-ala(8)-)
Recent Studies (post-2010) (neurokinin a (4-10), beta-ala(8)-)
9,1561875527102

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barnes, PJ; Hirayama, Y; Lei, YH; Rogers, DF1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and neurokinin a (4-10), beta-ala(8)-

ArticleYear
Effects of two novel tachykinin antagonists, FK224 and FK888, on neurogenic airway plasma exudation, bronchoconstriction and systemic hypotension in guinea-pigs in vivo.
    British journal of pharmacology, 1993, Volume: 108, Issue:3

    Topics: Animals; Blood Pressure; Bronchoconstriction; Capsaicin; Dipeptides; Electric Stimulation; Evans Blue; Exudates and Transudates; Guinea Pigs; Hypotension; Indoles; Male; Neurokinin A; Peptide Fragments; Peptides, Cyclic; Platelet Activating Factor; Receptors, Neurokinin-2; Receptors, Neurotransmitter; Respiratory Mechanics; Smoking; Substance P; Vagus Nerve

1993